Molecular alterations of p73 in human esophageal squamous cell carcinomas: Loss of heterozygosity occurs frequently; Loss of imprinting and elevation of p73 expression may be related to defective p53

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 683-689

  Cai, Yuyang Christine ^a   Yang, Guang Yu ^a   Nie, Van ^a   Wang, Li Dong ^b   Zhao, Xin ^a   Song, Yun Long ^a   Seril, Darren N ^a   Liao, Jie ^a   Xing, Eric Poe ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P53; PROTEIN P73;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; ESOPHAGUS CARCINOMA; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GENOME IMPRINTING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MESSENGER RNA SYNTHESIS; METHYLATION; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0034092061     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.683     Document Type: Article

References (39)

1. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T.D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
2. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes [see comments]. Nature, 362, 847-849.
3. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
4. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J., Valent, A., Minty, A., Chalon, P., Lelias, J., Dumont, X., Ferrara, P., McKeon, F. and Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
5. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V. andrews, N.C., Caput, D. and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol. Cell, 2, 305-316.
6. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M. and Ikawa, S. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53 [see comments]. Nature Med., 4, 839-843. [Erratum, Nature Med. (1998), 4, 982.]
7. Prabhu, N.S., Somasundaram, K., Satyamoorthy, K., Herlyn, M. and El-Deiry, W.S. (1998) p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. Int. J. Oncol., 13, 5-9.
8. Yuan, Z.M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y.Y., Lu, H., Kharbanda, S., Weichselbaum, R. and Kufe, D. (1999) p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature, 399, 814-817.
9. Agami, R., Blandino, G., Oren, M. and Shaul, Y. (1999) Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis [see comments]. Nature, 399, 809-813.
10. Gong, J.G., Costanzo, A., Yang, H.Q., Melino, G., Kaelin, W.G. Jr, Levrero, M. and Wang, J.Y. (1999) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage [see comments]. Nature, 399, 806-809.
11. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R. and Harris, C.C. (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146.
12. Kovalev, S., Marchenko, N., Swendeman, S., LaQuaglia, M. and Moll, U.M. (1998) Expression level, allelic origin and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ., 9, 897-903.
13. Yokomizo, A., Mai, M., Tindall, D.J., Cheng, L., Bostwick, D.G., Naito, S., Smith, D.I. and Liu, W. (1999) Overexpression of the wild type p73 gene in human bladder cancer. Oncogene, 18, 1629-1633.
14. Han, S., Semba, S., Abe, T., Makino, N., Furukawa, T., Fukushige, S., Takahashi, H., Sakurada, A., Sato, M., Shiiba, K., Matsuno, S., Nimura, Y., Nakagawara, A. and Horii, A. (1999) Infrequent somatic mutations of the p73 gene in various human cancers. Eur. J. Surg. Oncol., 25, 194-198.
15. Tsao, H., Zhang, X., Majewski, P. and Haluska, F.G. (1999) Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer Res., 59, 172-174.
16. Yokomizo, A., Mai, M., Bostwick, D.G., Tindall, D.J., Qian, J., Cheng, L., Jenkins, R.B., Smith, D.I. and Liu, W. (1999) Mutation and expression analysis of the p73 gene in prostate cancer. Prostate, 39, 94-100.
17. Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., Kaneko, Y., McKeon, F., Caput, D. and Nakagawara, A. (1999) p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene, 18, 1061-1066.
18. Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y.M. and Nakagawara, A. (1998) p73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer, 78, 437-440.
19. Kroiss, M.M., Bosserhoff, A.K., Vogt, T., Buettner, R., Bogenrieder, T., Landthaler, M. and Stolz, W. (1998) Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas. Melanoma Res., 8, 504-509.
20. White, E. and Prives, C. (1999) DNA damage enables p73 [news; comment]. Nature, 399, 734-735, 737.
21. Mai, M., Yokomizo, A., Qian, C., Yang, P., Tindall, D.J., Smith, D. and Liu, W. (1998) Activation of p73 silent allele in lung cancer. Cancer Res., 58, 2347-2349.
22. Mai, M., Qian, C., Yokomizo, A., Tindall, D.J., Bostwick, D., Polychronakos, C., Smith, D.I. and Liu, W. (1998) Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene, 17, 1739-1741.
23. Nomoto, S., Haruki, N., Kondo, M., Konishi, H. and Takahashi, T. (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58, 1380-1383.
24. Kawano, S., Miller, C.W., Gombart, A.F., Bartram, C.R., Matsuo, Y., Asou, H., Sakashita, A., Said, J., Tatsumi, E. and Koeffler, H.P. (1999) Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood, 94, 1113-1120.
25. Corn, P.G., Kuerbitz, S.J., van Noesel, M.M., Esteller, M., Compitello, N., Baylin, S.B. and Herman, J.G. (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res., 59, 3352-3356.
26. Sunahara, M., Ichimiya, S., Nimura, Y., Takada, N., Sakiyama, S., Sato, Y., Todo, S., Adachi, W., Amano, J. and Nakagawara, A. (1998) Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int. J. Oncol., 13, 319-323.
27. Loiseau, H., Arsaut, J. and Demotes-Mainard, J. (1999) p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas. Neurosci. Lett., 263, 173-176.
28. Zaika, A.I., Kovalev, S., Marchenko, N.D. and Moll, U.M. (1999) Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res., 59, 3257-3263.
29. Cook-Mozaffari, P. (1979) The epidemiology of cancer of the esophagus. Nutr. Cancer. 1, 51-60.
30. Warwick, G.P. (1973) Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv. Cancer Res., 17, 81-229.
31. Gao, H., Wang, L.D., Zhou, Q., Glodstein, S., Hong, J.Y., Shao, P., Qiu, S.L. and Yang, C.S. (1994) p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res., 54, 4342-4346.
32. Wang, L.D., Hong, J.Y., Qiu, S.L., Gao, H.K. and Yang, C.S. (1993) Accumulation of p53 protein in human esophageal precancerous lesions: a possible early marker for carcinogenesis. Cancer Res., 53, 1783-1787.
33. INK4a genes in human esophageal squamous cell carcinoma. Clin. Cancer Res., 5, 2704-2713.
34. Takahashi, H., Ichimja, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S. and Nakagawara, A. (1998) Mutation, allelotyping and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58, 2076-2077.
35. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T. and Takahashi, T. (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58, 1380-1383.
36. Mai, M., Huang, H., Reed, C., Qian, C., Smith, J., Alderete, B., Jenkins, R., Smith, D. and Liu, W. (1998) Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletion. Genomics, 51, 359-363.
37. Wilkins, R.J. (1998) Genomic imprinting and carcinogenesis. Lancet, 1, 329-331.
38. Wu, M., Wang, H., Lin, C., Sheu, J., Shun, C., Lee, W. and Lin, J. (1997) Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett., 120, 9-14.
39. Feinberg, A. (1993) Genomic imprinting and gene activation. Nature Genet., 4, 110-113.